| pubmed-article:10780315 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C1956346 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0016006 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0005330 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0020474 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0082608 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0006560 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C1420522 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10780315 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:10780315 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10780315 | pubmed:dateCreated | 2000-7-31 | lld:pubmed |
| pubmed-article:10780315 | pubmed:abstractText | We studied the effects of fluvastatin and bezafibrate in monotherapy and in combination on plasma fibrinogen, t-plasminogen activator inhibitor (PAI-1) and C reactive protein (CRP) in patients with coronary artery disease (CAD) and mixed hyperlipidaemia. | lld:pubmed |
| pubmed-article:10780315 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10780315 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780315 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10780315 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10780315 | pubmed:issn | 0340-6245 | lld:pubmed |
| pubmed-article:10780315 | pubmed:author | pubmed-author:MarianiMM | lld:pubmed |
| pubmed-article:10780315 | pubmed:author | pubmed-author:CortellaroMM | lld:pubmed |
| pubmed-article:10780315 | pubmed:author | pubmed-author:BoschettiCC | lld:pubmed |
| pubmed-article:10780315 | pubmed:author | pubmed-author:ManciniMM | lld:pubmed |
| pubmed-article:10780315 | pubmed:author | pubmed-author:PaolettiRR | lld:pubmed |
| pubmed-article:10780315 | pubmed:author | pubmed-author:CofrancescoEE | lld:pubmed |
| pubmed-article:10780315 | pubmed:author | pubmed-author:CortellaroFF | lld:pubmed |
| pubmed-article:10780315 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10780315 | pubmed:volume | 83 | lld:pubmed |
| pubmed-article:10780315 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10780315 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10780315 | pubmed:pagination | 549-53 | lld:pubmed |
| pubmed-article:10780315 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:meshHeading | pubmed-meshheading:10780315... | lld:pubmed |
| pubmed-article:10780315 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10780315 | pubmed:articleTitle | Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment. | lld:pubmed |
| pubmed-article:10780315 | pubmed:affiliation | University of Milan, Italy. centrorc@mailserver.unimi.it | lld:pubmed |
| pubmed-article:10780315 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10780315 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10780315 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10780315 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10780315 | lld:pubmed |
